Pharvaris N.V.PHVSNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-6.2%
5Y CAGR-7.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-6.2%/yr
Annual compound
5Y CAGR
-7.6%/yr
Consistent
Percentile
P43
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 50.31% |
| 2023 | 14.29% |
| 2022 | 60.32% |
| 2021 | 60.93% |
| 2020 | 249.53% |
| 2019 | 74.53% |
| 2018 | 0.00% |
| 2017 | 0.00% |